arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

BRAINSTORM CELL THERAPEUTICS INC.

BCLI

— Price unavailable

26 Visible periods

21 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Excellent

Bullish

auto_awesome

Analytical Summary

BRAINSTORM CELL THERAPEUTICS INC. shows strong fundamentals with top-quartile Return on Common Equity (%) and Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap —

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC 78.7% ↘

FCF / Share $-0.75 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity -0.10

info Valuation on last close.

26-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-10.31M

↑ +11.3% —

FCF / Share Free cash flow per share

$-0.75

↑ +58.4% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Returns ↓

Financial Health ↓

100

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Mar 31, 2006 10-K ↗	FY 2004 Mar 31, 2005 10-K ↗	FY 2003 Mar 31, 2004 10-K ↗	FY 2002 Mar 31, 2003 10-K ↗	FY 2001 Mar 31, 2002 10-K ↗	FY 2000 Sep 22, 2000 10-K ↗
EPS Growth YoY (%)	51.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	61.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	39.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	2.9% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	36.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	11.3% Fair ↓ Fair Declining Year-over-year change in net income	32.4% Excellent ↑ Excellent Improving Year-over-year change in net income	29.2% Excellent ↑ Excellent Improving Year-over-year change in net income	0.7% Caution ↑ Caution Improving Year-over-year change in net income	23.1% Good ↑ Good Improving Year-over-year change in net income	-36.8% Weak ↑ Weak Improving Year-over-year change in net income	-66.7% Weak ↓ Weak Declining Year-over-year change in net income	-181.7% Weak ↓ Weak Declining Year-over-year change in net income	0.6% Caution ↑ Caution Improving Year-over-year change in net income	41.3% Excellent ↑ Excellent Improving Year-over-year change in net income	8.2% Fair ↑ Fair Improving Year-over-year change in net income	-88.7% Weak ↑ Weak Improving Year-over-year change in net income	89.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-1112.6% Weak ↓ Weak Declining Year-over-year change in net income	-62.0% Weak ↓ Weak Declining Year-over-year change in net income	-35.8% Weak ↓ Weak Declining Year-over-year change in net income	48.7% Excellent Excellent Year-over-year change in net income	44.4% Excellent Excellent Year-over-year change in net income	—	—	82.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-25708.2% Weak ↓ Weak Declining Year-over-year change in net income	-55.3% Weak Weak Year-over-year change in net income	-80.8% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	58.4% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	74.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	10.3% Fair ↓ Fair Declining Year-over-year change in free cash flow	27.9% Excellent Excellent Year-over-year change in free cash flow	38.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Mar 31, 2006 10-K ↗	FY 2004 Mar 31, 2005 10-K ↗	FY 2003 Mar 31, 2004 10-K ↗	FY 2002 Mar 31, 2003 10-K ↗	FY 2001 Mar 31, 2002 10-K ↗	FY 2000 Sep 22, 2000 10-K ↗
FCF / Net Income (x)	0.68x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.19x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.12x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.50x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.51x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.20x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.50x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.33x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.58x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Mar 31, 2006 10-K ↗	FY 2004 Mar 31, 2005 10-K ↗	FY 2003 Mar 31, 2004 10-K ↗	FY 2002 Mar 31, 2003 10-K ↗	FY 2001 Mar 31, 2002 10-K ↗	FY 2000 Sep 22, 2000 10-K ↗
Return on Invested Capital (%)	78.7% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	119.0% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	348.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	650.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-100.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-70.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	148.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-221.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-67.2% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-40.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-47.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-109.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-141.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-937.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-207.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-413.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Return on Capital (%) (%)	-973.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-638.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-509.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-293.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-83.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-61.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-352.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-125.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-43.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-47.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-50.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-93.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-103.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-890.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-142.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	220.4% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	103.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+588%)	149.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+898%)	—	—	-126.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-943%)	-89.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-698%)	190.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1168%)	-278.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1954%)	-84.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-661%)	-50.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-435%)	-60.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-501%)	-138.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1023%)	-178.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1292%)	—	-263.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1855%)	—	102.2% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+581%)	167.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1015%)	257.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1614%)	—	41.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+180%)	—	235.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1470%)	-223.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1592%)	-49.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-427%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Mar 31, 2006 10-K ↗	FY 2004 Mar 31, 2005 10-K ↗	FY 2003 Mar 31, 2004 10-K ↗	FY 2002 Mar 31, 2003 10-K ↗	FY 2001 Mar 31, 2002 10-K ↗	FY 2000 Sep 22, 2000 10-K ↗
Debt to Equity (x)	-0.10x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-116%)	-0.04x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-106%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	-19.26x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-25.91x Weak Weak Operating income divided by interest expense Optimal: > 5x	12.70x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$938.00K	$113.00K	$-1.30M	$-772.00K	$-18.86M	$-37.83M	$-536.00K	$-942.00K	$-2.48M	$-547.00K	$-428.00K	$-4.25M	$-3.50M	$-1.32M	$-1.92M	$-749.00K	$-1.00K	—	—	—	—	—	—	—	—	$0.00
Debt / EBITDA (x)	-0.10x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.03x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Mar 31, 2006 10-K ↗	FY 2004 Mar 31, 2005 10-K ↗	FY 2003 Mar 31, 2004 10-K ↗	FY 2002 Mar 31, 2003 10-K ↗	FY 2001 Mar 31, 2002 10-K ↗	FY 2000 Sep 22, 2000 10-K ↗
Basic EPS, GAAP (USD)	$-1.11	$-2.31	$-5.97	$-9.85	$-10.15	$-15.97	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.75	$-1.81	$-7.09	$-7.91	$-10.97	$-17.79	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-0.90	$-1.26	$-1.20	$-1.23	$7.93	$15.05	$-7.87	$3.61	$4.62	$7.91	$11.31	$6.52	$3.48	$0.40	$0.18	$-0.07	—	—	—	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$-0.90	$-1.26	$-1.20	$-1.23	$7.93	$15.05	$-7.87	$3.61	$4.62	$7.91	$11.31	$6.52	$3.48	$0.40	$0.18	$-0.07	—	—	—	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	9.27M	5.02M	2.89M	2.45M	2.42M	2.00M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Mar 31, 2006 10-K ↗	FY 2004 Mar 31, 2005 10-K ↗	FY 2003 Mar 31, 2004 10-K ↗	FY 2002 Mar 31, 2003 10-K ↗	FY 2001 Mar 31, 2002 10-K ↗	FY 2000 Sep 22, 2000 10-K ↗
Working Capital (USD)	$-10.70M	$-8.59M	$-5.90M	$-5.69M	$16.96M	$32.01M	$-14.29M	$4.06M	$4.08M	$9.58M	$13.84M	$6.46M	$3.11M	$3.73M	$1.17M	$-844.00K	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$-9.98M	$-7.76M	$-4.86M	$-3.02M	$19.34M	$35.46M	$-12.22M	$5.02M	$5.88M	$9.90M	$14.13M	$6.67M	$2.74M	$3.98M	$1.49M	$-459.00K	$-1.74M	$-2.08M	$-2.43M	$-1.82M	$-7.91M	$704.00K	$-31.00K	$21.00K	$53.00K	$0.00

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Mar 31, 2006 10-K ↗	FY 2004 Mar 31, 2005 10-K ↗	FY 2003 Mar 31, 2004 10-K ↗	FY 2002 Mar 31, 2003 10-K ↗	FY 2001 Mar 31, 2002 10-K ↗	FY 2000 Sep 22, 2000 10-K ↗
Depreciation Expense (USD)	$199.00K	$240.00K	$265.00K	$285.00K	$260.00K	$219.00K	$164.00K	$110.00K	$85.00K	$77.00K	$87.00K	$106.00K	$97.00K	$157.00K	$153.00K	—	—	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-10.31M	$-11.62M	$-17.19M	$-24.28M	$-24.46M	$-31.81M	$-23.25M	$-13.95M	$-4.95M	$-4.98M	$-8.49M	$-9.25M	$-4.90M	$-47.51M	$-3.92M	$-2.42M	$-1.78M	$-3.47M	$-6.24M	—	$-3.32M	$-18.84M	$-73.00K	$-47.00K	$-26.00K	—
Operating Cash Flow (USD)	$-6.97M	$-9.09M	$-20.46M	$-19.32M	$-26.27M	$-35.19M	$-11.25M	$-12.39M	$-2.36M	$-5.86M	—	$-4.49M	$-4.05M	$-14.29M	$-2.22M	$-2.07M	—	—	—	—	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 26 years · 101 quarters

BRAINSTORM CELL THERAPEUTICS INC.

Analytical Summary

26-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BCLI with peers